Position in LH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,005,520
-$147,639 QoQ
Shares Held
10,734
-9.2% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#318
of 1,044 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026NEUBERGER BERMAN GROUP LLC holds $1,788,467,774 across 25 Diagnostics & Research names. LH ranks #18 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
1,853,198 | $352,997,154 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
667,506 | $334,660,807 | |
| 3 | WAT |
Waters Corp /De/
|
638,786 | $239,570,301 | |
| 4 | RVTY |
Revvity, Inc.
|
1,876,041 | $208,728,321 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
862,704 | $195,652,639 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
353,322 | $186,002,833 | |
| 7 | BLLN |
BillionToOne, Inc.
|
764,215 | $91,690,515 | |
| 8 | NTRA |
Natera, Inc.
|
211,732 | $57,474,650 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,005,520 | 10,734 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,153,159 | 11,818 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $3,013,570 | 12,012 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,619,538 | 12,609 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $4,883,735 | 18,604 | Shares | Defined | 2025-08-25 | |
| 2025-03-31 | $4,068,062 | 17,479 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,760,388 | 16,398 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $2,496,941 | 11,173 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,745,504 | 8,577 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||